Salute e Benessere

GENFIT: May 24, 2023 Combined Shareholders Meeting results

Quorum of 29.54%on first convening; allowing approvalof all the resolutionsrecommended by the Board of DirectorsLille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); May 24 , 2023-GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced the results of the Combined Shareholders Meeting which took place on May...
Nasdaq GlobeNewswire
24/05/2023

Annual Meeting of Shareholders June 13, 2023 / Availability of preparatory…

Annual Meeting of ShareholdersJune 13 , 2023Availability of preparatory documentsParis, France , May24 , 2023– 19:00 CET– Pixium Vision SA (Euronext Growth Paris - FR0011950641), a bioelectronics company that develops innovative bionic vision systems to enable patients who have lost their sight to live more independent lives, informs its shareholders that its Annual Meeting of the Company will be held on June 13, 2023, at 2.00 pm CET at the headquarter of...
Nasdaq GlobeNewswire
24/05/2023

Biobanking Market worth $5.0 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=594 Browse in-depth TOC on "Biobanking Market" 380 - Tables 46 - Figures 324 - Pages Biobanking Market Scope: The blood products segment accounted for the largest share, by sample type in the biobanking market in 2022. Based on sample type, the global biobanking market has...
PR Newswire
24/05/2023

Cymbiotika Pioneers a New Market in the UAE, Introducing Hassle-Free Shopping…

"Cymbiotika is thrilled to enter the UAE market and bring our premium health and wellness products to the discerning consumers in this vibrant region," said Shahab Elmi, CEO and co-founder of Cymbiotika. "By eliminating custom fees and offering localized pricing, we are breaking barriers and making it easier for UAE residents to prioritize their well-being. We believe everyone deserves access to high-quality health solutions, and this launch is a testament to our commitment to…
PR Newswire
24/05/2023

DSM-Firmenich AG launches the sale of up to c. 6.7 million existing…

KAISERAUGST, Switzerland and HEERLEN, Netherlands, May 24, 2023 /PRNewswire/ -- DSM-Firmenich AG (the "Company" or DSM-Firmenich) announces the launch of the sale of up to 6,696,477 existing DSM-Firmenich ordinary shares, representing approximately 2.5% of DSM-Firmenich's share capital, through an accelerated bookbuild offering, which will start immediately following the publication of this announcement (the "Share Placement"). KAISERAUGST,Switzerlandand…
PR Newswire
24/05/2023

Brain Computer Interface (BCI) Enables Thought-Controlled Walking after Spinal…

Pioneering study in Nature demonstrates that adding a BCI to ONWARD® ARC Therapy™ can enable thought-controlled standing, walking, and stair climbing Natureshowing that a wireless brain-computer interface (BCI) can use thought to modulate ARC Therapy. Researchers reported that when paired with ARC Therapy, an implanted BCI allowed an individual to gain augmented control over when and how he moved his paralyzed legs. “This publication shows the remarkable potential of ARC Therapy to be...
Nasdaq GlobeNewswire
24/05/2023

GN Store Nord A/S announces plan to strengthen its capital structure to execute…

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION WHERE THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURESTHIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFERING MEMORANDUM OR A PROSPECTUS AS DEFINED BY REGULATION (EU) NO. 2017/1129 OF 14 JUNE 2017.GN Store Nord A/S announces plan to strengthen its capital structure to...
Nasdaq GlobeNewswire
24/05/2023

Relapsed/Refractory Acute Myeloid Leukemia Market Growing Rapidly, Estimates…

Key Takeaways from the Relapsed/Refractory Acute Myeloid Leukemia Market Report Key Takeaways from the Relapsed/Refractory Acute Myeloid Leukemia Market Report Discover which therapies are expected to grab the major relapsed/refractory acute myeloid leukemia market share @Relapsed/Refractory Acute Myeloid Leukemia Market Report Relapsed/Refractory Acute Myeloid Leukemia Overview Acute myeloid leukemia (AML) is a type of hematologic cancer that is distinguished by the clonal...
PR Newswire
24/05/2023

Hemostasis Diagnostics Market to Grow Significantly by 2029- Brandessence Market…

Key takeaways Key takeaways The Hemostasis Diagnostics Market was worthUSD 2228.8 millionin 2018 and is anticipated to accrue a valuation ofUSD 3948.6 millionby 2025, registering a CAGR of 8.1% over 2022-2029. Get Sample of Report@ https://brandessenceresearch.com/downloadSample/PostId/256 Elaborating the key trends and dynamics of Hemostasis Diagnostics Market Increasing occurrences of blood clotting disorders, growing awareness about such disorders, and rising...
PR Newswire
24/05/2023

Apheresis Market to Grow Remarkably by 2029- Brandessence Market Research

Key takeaways Key takeaways The Apheresis Market is anticipated to garner significant returns over the assessment timeline of 2022-2029. Get Sample of Report@https://brandessenceresearch.com/downloadSample/PostId/262 Elaborating the key trends and dynamics of Apheresis Market Escalating demand for blood components worldwide, increased incidences of severe injuries, and favourable government efforts to raise awareness on blood donation are primarily aiding the expansion of...
PR Newswire
24/05/2023

Disposable Gloves Market to Grow Exponentially by 2029- Brandessence Market…

Key takeaways Key takeaways The Disposable Gloves Market is anticipated to generate significant returns over the assessment timeline of 2022-2029. Get Sample of Report@ https://brandessenceresearch.com/downloadSample/PostId/261 Elaborating the key trends and dynamics of the Disposable Gloves Market Growing prevalence of infectious diseases, rising product adoption in the healthcare sector, and increased hygiene consciousness among the masses are primarily augmenting the...
PR Newswire
24/05/2023

ClearPoint Neuro and UCB Enter License Agreement for Gene Therapy Drug Delivery

“We are extremely excited to partner with UCB, a global biopharmaceutical leader, with a focus on innovating through the adoption of next generation science and new technologies,” stated Jeremy Stigall, Executive Vice President and General Manager of Biologics and Drug Delivery at ClearPoint Neuro. “Over the past year, we have invested heavily in expanding our Biologics and Drug Delivery team, as well as our product and services portfolio to attract partners of UCB's caliber. UCB sought...
Nasdaq GlobeNewswire
24/05/2023

Healthcare Predictive Analytics Market to Experience Exponential Growth at a…

Request Sample PDF of the Report: https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/healthcare-predictive-analytics-market/87505 Request Sample PDF of the Report: https://www.extrapolate.com/sample/healthcare-medical-devices-biotechnology/healthcare-predictive-analytics-market/87505 Competitive Landscape The healthcare predictive analytics market is fragmented in terms of domestic and international players. Additionally, numerous start-up businesses are...
PR Newswire
24/05/2023

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

BOSTON and LONDON, May24, 2023(GLOBE NEWSWIRE) --Centessa Pharmaceuticals plc(Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop transformational medicines for patients, today announced that members of its management team will participate in the following investor conferences:Event:Jefferies Global Healthcare ConferenceDate:Friday, June 9, 2023Location:New York, NYFireside Chat:10:30 AM ET Event:Goldman Sachs 44 thAnnual...
Nasdaq GlobeNewswire
24/05/2023

Oxitec Launches New Technology Program to Develop a Friendly™ Solution for the…

Launched in 2021, Oxitec's cattle tick program has conducted in-depth assessments of tick biology and genetics, assessed methods for development of a Friendly™ tick solution, artificial production methods, cattle management practices in regions threatened by R. microplus, and modelled the impact of future implementation on target tick populations. The results of this rigorous feasibility phase demonstrated that a future Friendly™ cattle tick solution could deliver highly effective R. microplus…
PR Newswire
24/05/2023

Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin…

"Like Endo, MAIA is laser-focused on delivering meaningful solutions to support healthcare providers as they deliver quality patient care," said Brian Cooney, Sr. Director, Corporate Development at MAIA Pharmaceuticals. "We are pleased to partner with Endo to provide ready-to-use bivalirudin, which requires no reconstitution, no dilution and no mixing." "Like Endo, MAIA is laser-focused on delivering meaningful solutions to support healthcare providers as they deliver…
PR Newswire
24/05/2023

Biopharma Leaders Connect at Veeva R&D and Quality Summit to Advance Innovation…

Veeva R&D and Quality Summit will bring together more than 750 industry professionals to participate in over 40 sessions. Attendees will learn about strategies for developing the foundation for clinical operations and data in patient-centric trials, elevating quality management beyond compliance, streamlining regulatory processes, and improving oversight and efficiency in safety. Veeva R&D and Quality Summit will bring together more than 750 industry professionals to participate in over…
PR Newswire
24/05/2023

Director/PDMR Shareholding

DXS INTERNATIONAL PLC Notification of Director / PDMR DealingThe Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems confirms that the Placing Shares and the Stakeholder Shares referred to in the Announcement of 17 thMay have this morning been admitted to trading on the Aquis Stock Exchange.As part of the Placing and Conversion of Debt Mr Bob Sutcliffe, the Chairman, has...
Nasdaq GlobeNewswire
24/05/2023

Director/PDMR Shareholding

DXS INTERNATIONAL PLC Notification of Director / PDMR DealingThe Board of DXS International plc (the “Company”), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems confirms that the Placing Shares and the Stakeholder Shares referred to in the Announcement of 17th May have this morning been admitted to trading on the Aquis Stock Exchange.As part of the Placing and Conversion of Debt DL Services Limited, (a company owned and...
Nasdaq GlobeNewswire
24/05/2023

Orthodontics Market on a Growth Trajectory: CAGR of 18.8%.Highlights Positive…

Orthodontic treatments aim to achieve optimal oral health by addressing various issues, including crooked teeth, crowded teeth, gaps between teeth, overbites, underbites, crossbites, and other malocclusions (bite problems). These dental irregularities can cause difficulties in chewing, speaking, and maintaining proper oral hygiene. An orthodontist is a dental specialist who undergoes additional years of training after dental school to acquire expertise in orthodontics. They are skilled in the…
PR Newswire
24/05/2023

JBD launches "Hummingbird" polychrome MicroLED projector, an industry supremacy…

With a luminous flux output ranging 3-5 lumens, the JBD Hummingbird offers a standard viewing angle of 30°, which can be customized within the range of 25° to 45°. Coupled with a decent optical waveguide, it achieves an impressive brightness of 1800 nits, ensuring clear visibility of screen contents even in bright outdoor environments. When it comes to battery life, the JBD Hummingbird benefits from the high luminous efficacy of JBD's MicroLED technology. Under typical operating conditions, the…
PR Newswire
24/05/2023

Patient Simulator Market to Reach $1.2 Billion, Globally, by 2032 at 8.7% CAGR…

Download Sample Copy of the Report- https://www.alliedmarketresearch.com/request-sample/12032 Download Sample Copy of the Report-https://www.alliedmarketresearch.com/request-sample/12032 Prime determinants of growth Growing focus on patient safety, increase in awareness regarding simulation based training and technological advancement drive the growth of the global patient simulator market. However, inflated cost of simulators, need of upgrading and maintaining the simulators are...
PR Newswire
24/05/2023

Head and Neck Cancer Market Worth US$ 5.0 billion by 2032, with a CAGR of 12.9%…

Cancer is the type of disease where abnormal cells are developed and divided into uncontrollable manner. Head and neck squamous cell carcinoma (HNSCC) that comprising upper aero digestive tract anatomic sites represents cause of cancer death across the globe. Cancer is the type of disease where abnormal cells are developed and divided into uncontrollable manner. Head and neck squamous cell carcinoma (HNSCC) that comprising upper aero digestive tract anatomic sites represents cause of cancer...
PR Newswire
24/05/2023

Novo Nordisk and Life Edit Therapeutics establish multi-target collaboration to…

Life Edit will receive an upfront cash payment and is eligible to receive milestone payments of 250-335 million US dollars for each of seven development programmes , as well as tiered royalties on global net sales .Life Edithas the option to aglobal profit share on one programme .Novo Nordisk will make an equity investment in ElevateBio , Life Edit's parent company, as part of ElevateBio's401 million US dollars Series D financing .Bagsværd,...
Nasdaq GlobeNewswire
24/05/2023
Altri  Comunicati